These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 875336)

  • 21. [Pharmacology of a new anti-angina preparation, nonachlazin].
    Kaverdina NV; Markova GA
    Farmakol Toksikol; 1975; 38(2):173-7. PubMed ID: 1227883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanism of nonachlazine on cardiac activity and blood supply].
    Kaverina NV; Griglevskiĭ R; Basaeva AI; Markova GA; Chumburidze VB
    Biull Eksp Biol Med; 1975 Nov; 80(11):48-50. PubMed ID: 1218260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of nonachlazine in the treatment of chronic ischemic heart disease].
    Evtushenko VI; Zakharov NM; Knysh VI; Martynov VI
    Voen Med Zh; 1979 Mar; (3):59-60. PubMed ID: 452467
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of curantyl on myocardial contractility and regional blood circulation in patients with ischemic heart disease].
    Del'va IuV; Neĭko EM
    Vrach Delo; 1976 Jun; (6):23-6. PubMed ID: 969452
    [No Abstract]   [Full Text] [Related]  

  • 25. [Tolerance to physical exercise in patients with chronic coronary insufficiency treated with anticoagulants].
    Gritsiuk AI; Kucheriavyĭ PG; Terno VS
    Ter Arkh; 1982; 54(3):49-51. PubMed ID: 7089886
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of visken and cordarone on myocardial function in patients with ischemic heart disease].
    Cherevatov BG; Kucherenko OD; Boiarshin SV
    Sov Med; 1983; (8):65-7. PubMed ID: 6648656
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic actions on alinidine during exercise in patients with coronary artery disease.
    Löllgen H; Just H; Wollschläger H; Kersting F
    Z Kardiol; 1981 May; 70(5):425-8. PubMed ID: 7269729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiopulmonary diagnosis in patients with ischemic heart disease].
    Schauer J; Urbaszek W; Günther K; Pankau H
    Z Gesamte Inn Med; 1976 Jan; 31(2):310-4. PubMed ID: 960885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in contractility parameters, coronary flow and myocardial oxygen consumption following intravenous diltiazem in patients with coronary heart disease].
    Oeff M; Schröder R; Biamino G
    Z Kardiol; 1984 Nov; 73(11):717-23. PubMed ID: 6523970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathophysiology of angina pectoris and the effect of lidoflazine.
    Gobel FL; Nordstrom LA; Nelson RR; Wang Y
    Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of verapamil on left ventricular contraction in patients with coronary disease].
    Goch JH; Kuklewicz C; Organiszczak K; Tkaczewski W
    Wiad Lek; 1976 Sep; 29(17):1502-4. PubMed ID: 983029
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of propranolol on ECG and triglyceride and noradrenaline levels in the blood during long-term physical exertion in patients with coronary disease].
    Ziółkowski L; Wójcik EJ; Krzemiński K
    Przegl Lek; 1986; 43(11):706-11. PubMed ID: 3575773
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prognostic assessment of coronary heart disease by measurement of heart size and quantification of load ischemia].
    Bussmann WD; Giebeler B; Rose DM; Kaltenbach M
    Lebensversicher Med; 1982 Jul; 34(6):129-31. PubMed ID: 6126788
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of nitroglycerin on left ventricular contraction in ischemic heart disease].
    Ekha IaE; Lukha OA; Leĭssoo AR
    Klin Med (Mosk); 1981 Mar; 59(3):36-40. PubMed ID: 6790816
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ultrasonocardiographic evaluation of the nitroglycerin effect on left-ventricular size and myocardial contractility in coronary disease].
    Trojnar R; Rymar B; Dubejko J; Markiewicz M
    Pol Tyg Lek; 1980 Dec; 35(48):1853-5. PubMed ID: 6782557
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative analysis of pathophysiologic mechanisms of myocardial infarction development under conditions of physical and information load in patients with ischemic heart disease].
    Sudzhaeva SG
    Patol Fiziol Eksp Ter; 1990; (5):13-5. PubMed ID: 2293150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antianginal drug effects on normal, ischemic and scar myocardial segments in man.
    Pfisterer M; Fridrich R; Burkart F
    Scand J Clin Lab Invest Suppl; 1984; 173():65-73. PubMed ID: 6442004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of ethacizin].
    Kaverina NV; Skoldinov AP; Senova ZP; Gritsenko AN; Lyskovtsev VV
    Farmakol Toksikol; 1985; 48(5):43-9. PubMed ID: 3908141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of nifedipine on the dynamics of heart's contraction and effort tolerance in patients with coronary disease].
    Adamska-Dyniewska H; Atta W
    Pol Tyg Lek; 1976 Aug; 31(34):1485-7. PubMed ID: 980964
    [No Abstract]   [Full Text] [Related]  

  • 40. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.